Cyrille Touzeau

47PUBLICATIONS
165CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMedical mycologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 29, 2026
BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Feb 25, 2026
Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM).

Alexis Talbot, Bernard Delcour, Laurent Gillot

|Oct 24, 2025
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Philippe Moreau, Cyrille Hulin, Alexis Talbot

|Sep 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges.

Cyrille Touzeau, Philippe Moreau

|Aug 07, 2025
Simultaneous whole-body multi-parametric 2-[18F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact.

Bastien Jamet, Cyrille Touzeau, Hatem Necib

Pageof 8

Frequent Collaborators

19 joint publications

Philippe Moreau

10 joint publications

Aurore Perrot

9 joint publications

Jill Corre

8 joint publications

Xavier Leleu